Allergan PLC has been hit with a proposed class action lawsuit in Manhattan federal court accusing the company of concealing from investors that textured breast implants it manufactured have been linked to a rare form of cancer.
Wednesday’s lawsuit comes after Allergan’s announcement last week that it would take its textured breast implants off the market in Europe after a French regulatory body on Dec. 18 ordered a recall.
To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2QVhdOg
Our Standards: The Thomson Reuters Trust Principles.